AMOXICILLIN AND CLAVULANATE POTASSIUM Drug Patent Profile
✉ Email this page to a colleague
When do Amoxicillin And Clavulanate Potassium patents expire, and what generic alternatives are available?
Amoxicillin And Clavulanate Potassium is a drug marketed by Aurobindo Pharma, Aurobindo Pharma Ltd, Deva Holding As, Hikma Pharms, Micro Labs, Micro Labs Ltd India, Sandoz, Sandoz Inc, Sun Pharm Inds Ltd, Teva, Wockhardt Bio Ag, Apotex Inc, and Teva Pharms Usa. and is included in forty-one NDAs.
The generic ingredient in AMOXICILLIN AND CLAVULANATE POTASSIUM is amoxicillin; clavulanate potassium. There are forty-six drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the amoxicillin; clavulanate potassium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Amoxicillin And Clavulanate Potassium
A generic version of AMOXICILLIN AND CLAVULANATE POTASSIUM was approved as amoxicillin; clavulanate potassium by SANDOZ on March 14th, 2002.
Summary for AMOXICILLIN AND CLAVULANATE POTASSIUM
US Patents: | 0 |
Applicants: | 13 |
NDAs: | 41 |
Finished Product Suppliers / Packagers: | 32 |
Raw Ingredient (Bulk) Api Vendors: | 12 |
Clinical Trials: | 18 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in AMOXICILLIN AND CLAVULANATE POTASSIUM? | AMOXICILLIN AND CLAVULANATE POTASSIUM excipients list |
DailyMed Link: | AMOXICILLIN AND CLAVULANATE POTASSIUM at DailyMed |
Recent Clinical Trials for AMOXICILLIN AND CLAVULANATE POTASSIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Second Affiliated Hospital of Wenzhou Medical University | N/A |
Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
Alphacait, LLC | Phase 2 |
See all AMOXICILLIN AND CLAVULANATE POTASSIUM clinical trials
Pharmacology for AMOXICILLIN AND CLAVULANATE POTASSIUM
Drug Class | Penicillin-class Antibacterial beta Lactamase Inhibitor |
Mechanism of Action | beta Lactamase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for AMOXICILLIN AND CLAVULANATE POTASSIUM
US Patents and Regulatory Information for AMOXICILLIN AND CLAVULANATE POTASSIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Deva Holding As | AMOXICILLIN AND CLAVULANATE POTASSIUM | amoxicillin; clavulanate potassium | TABLET;ORAL | 209992-001 | Sep 15, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Teva | AMOXICILLIN AND CLAVULANATE POTASSIUM | amoxicillin; clavulanate potassium | TABLET, CHEWABLE;ORAL | 065205-001 | Feb 9, 2005 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sandoz | AMOXICILLIN AND CLAVULANATE POTASSIUM | amoxicillin; clavulanate potassium | TABLET;ORAL | 065063-001 | Mar 14, 2002 | AB | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |